Dementia research at UCL has received a major new investment of £15 million for the Alzheimer’s Research UK Drug Discovery Institute at UCL. Alzheimer’s Research UK announced the funding as it renews its flagship Drug Discovery Alliance at a pivotal moment for dementia research. UCL’s Drug Discovery Institute was launched in 2015 with an aim to turn more early‑stage scientific discoveries into potential new treatments. Alongside two other centres at the Universities of Cambridge and Oxford,